ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 208734 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 208734; 2) Community: the network communities that were significantly associated with the response to NSC 208734; 3) Molecule: the relationships between components within communities and NSC 208734; 4) MDR: the compounds that were significantly associated with the NSC 208734.

NSC Compound Enrichment Correlation
NSC 757113 METHOTREXATE(+/-) 0.00770426557728506 0.383408
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.00803384002766641 0.4504054
NSC 244404 Null 0.00803384002766641 0.3060643
NSC 254665 JUSTICIDIN B 0.00803384002766641 0.15918978
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.00803384002766641 0.49334596
NSC 303861 L-Cysteine analog 0.00803384002766641 0.45649422
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.00803384002766641 0.42203686
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.00803384002766641 0.46959864
NSC 606497 Camptothecin Derivative 0.00803384002766641 0.31137468
NSC 644622 Null 0.00803384002766641 0.31037181
Total:69  Current:15    [First] [Prev] [Next] [Last]